Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

September 01, 1986; Volume 30,Issue 3
  • You have access
    Effect of solubilization on the distinct binding properties of muscarine receptors from rabbit hippocampus and brainstem.
    D D Flynn and L T Potter
    Molecular Pharmacology September 1986, 30 (3) 193-199;
  • You have access
    Receptor reserve in the calcium-dependent cyclic AMP response of astrocytoma cells to muscarinic receptor stimulation: demonstration by agonist-induced desensitization, receptor inactivation, and phorbol ester treatment.
    T K Harden, M M Heng and J H Brown
    Molecular Pharmacology September 1986, 30 (3) 200-206;
  • You have access
    Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115): cyclic GMP formation is mediated by a low affinity agonist-receptor conformation and cyclic AMP reduction is mediated by a high affinity agonist-receptor conformation.
    M McKinney and E Richelson
    Molecular Pharmacology September 1986, 30 (3) 207-211;
  • You have access
    Characterization of the binding of [3H]-(+/-)-L-364,718: a new potent, nonpeptide cholecystokinin antagonist radioligand selective for peripheral receptors.
    R S Chang, V J Lotti, T B Chen and K A Kunkel
    Molecular Pharmacology September 1986, 30 (3) 212-217;
  • You have access
    Modulation of the chloride ionophore by benzodiazepine receptor ligands: influence of gamma-aminobutyric acid and ligand efficacy.
    K W Gee, L J Lawrence and H I Yamamura
    Molecular Pharmacology September 1986, 30 (3) 218-225;
  • You have access
    The thermodynamics of agonist and antagonist binding to dopamine D-2 receptors.
    G J Kilpatrick, N el Tayar, H Van de Waterbeemd, P Jenner, B Testa and C D Marsden
    Molecular Pharmacology September 1986, 30 (3) 226-234;
  • You have access
    Leukotriene B4 induces formation of inositol phosphates in rat peritoneal polymorphonuclear leukocytes.
    S Mong, G Chi-Rosso, J Miller, K Hoffman, K A Razgaitis, P Bender and S T Crooke
    Molecular Pharmacology September 1986, 30 (3) 235-242;
  • You have access
    Association of a spin-labeled local anesthetic with the allosterically coupled noncompetitive inhibitor site on the acetylcholine receptor.
    A Palma, J M Herz, H H Wang and P Taylor
    Molecular Pharmacology September 1986, 30 (3) 243-251;
  • You have access
    [3H]Dihydrotetrabenazine binding to bovine striatal synaptic vesicles.
    J A Near
    Molecular Pharmacology September 1986, 30 (3) 252-257;
  • You have access
    Dopaminergic 2-aminotetralins: affinities for dopamine D2-receptors, molecular structures, and conformational preferences.
    A M Johansson, A Karlén, C J Grol, S Sundell, L Kenne and U Hacksell
    Molecular Pharmacology September 1986, 30 (3) 258-269;
  • You have access
    Effects of sodium valproate on mitochondrial membranes: electron paramagnetic resonance and transmembrane protein movement studies.
    L Rumbach, C Mutet, G Cremel, C A Marescaux, G Micheletti, J M Warter and A Waksman
    Molecular Pharmacology September 1986, 30 (3) 270-273;
  • You have access
    Effects of nitroprusside on the bradykinin responsiveness of human fibroblasts.
    S C Tsai, R Adamik, B E Hom, V C Manganiello and J Moss
    Molecular Pharmacology September 1986, 30 (3) 274-278;
  • You have access
    A theoretical study of the comparative binding affinities of daunomycin derivatives to a double-stranded oligomeric DNA. Proposal for new high affinity derivatives.
    K X Chen, N Gresh and B Pullman
    Molecular Pharmacology September 1986, 30 (3) 279-286;
  • You have access
    Oxidation of quinidine by human liver cytochrome P-450.
    F P Guengerich, D Müller-Enoch and I A Blair
    Molecular Pharmacology September 1986, 30 (3) 287-295;
  • You have access
    The cytochrome P-450 monooxygenase system of rabbit lung enzyme components, activities, and induction in the nonciliated bronchiolar epithelial (Clara) cell, alveolar type II cell, and alveolar macrophage.
    B A Domin, T R Devereux and R M Philpot
    Molecular Pharmacology September 1986, 30 (3) 296-303;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 30, Issue 3
1 Sep 1986
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics